Teva, Marijuana, Pandora, Malibu: Intellectual Property

Sept. 13 (Bloomberg) -- Teva Pharmaceuticals USA Inc. and Par Pharmaceutical Cos. won an appeal in their bid to sell a generic version of BASF SE’s heart medicine Lovaza in the U.S.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.